NEURO-DEGENERATIVE DISEASE
Clinical trials for NEURO-DEGENERATIVE DISEASE explained in plain language.
Never miss a new study
Get alerted when new NEURO-DEGENERATIVE DISEASE trials appear
Sign up with your email to follow new studies for NEURO-DEGENERATIVE DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New oral drug enters human testing for devastating ALS
Disease control Not yet recruitingThis early-stage study is testing a new oral drug called Kamlanoflast in 40 people with ALS (amyotrophic lateral sclerosis). The main goals are to check if the drug is safe and tolerable when taken for 24 weeks, and to see how it affects markers of inflammation and physical funct…
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Inflammasome Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Backward-Pedaling bike could ease MS symptoms
Symptom relief Not yet recruitingThis study is testing if a special type of cycling, called eccentric cycling, can help people with multiple sclerosis (MS) feel better. Researchers will compare this new exercise to regular cycling to see which one is more effective at improving muscle strength, walking ability, …
Matched conditions: NEURO-DEGENERATIVE DISEASE
Phase: NA • Sponsor: University of Liege • Aim: Symptom relief
Last updated Mar 25, 2026 14:08 UTC